Trial · NCT01894581
Effects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese Women
NCT01894581, Not applicable, Completed, University of Colorado, Denver; results first posted 2016-07-13
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese Women. Trials, record NCT01894581. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01894581
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese Women
- NCT number
- NCT01894581
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 39 participants, actual
- Lead sponsor
- University of Colorado, Denver
- Conditions
- Obesity, Fertility
- Interventions
- LOVAZA, GnRH
- First posted
- 2013-07-10
- Last updated
- 2017-02-02
- Results first posted
- 2016-07-13
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in the Average LH Pulse Amplitude | 10 minute intervals during 8 hour blood sampling studies. Subjects will undergo two menstrual cycles of study, one prior to dietary supplementation and one after supplementation. | To test the pituitary and hypothalamic output, we examined LH secretion (unstimulated and in response to gonadotropin-releasing hormone (GnRH) stimulation) during 8-hour blood sampling studies at 10 min intervals. The primary outcome measure is the change in the average LH pulse amplitude for each patient from baseline to after supplementation. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change in the Average LH Pulse Amplitude | 10 minute intervals during 8 hour blood sampling studies. Subjects will undergo two menstrual cycles of study, one prior to dietary supplementation and one after supplementation. | IU/L | MEAN |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in the Average LH Pulse Amplitude | Obese | -.04 | Standard Deviation .2 | IU/L | |
| Change in the Average LH Pulse Amplitude | Normal Weight | .4 | Standard Deviation .4 | IU/L |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Obese | 20 | |
| Overall Study | STARTED | Normal Weight | 19 | |
| Overall Study | COMPLETED | Obese | 15 | |
| Overall Study | COMPLETED | Normal Weight | 12 | |
| Overall Study | NOT COMPLETED | Obese | 5 | |
| Overall Study | NOT COMPLETED | Normal Weight | 7 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Obese | ||
| Total, all-cause mortality | Normal Weight | ||
| Total, other adverse events | Obese | 0 | 15 |
| Total, other adverse events | Normal Weight | 0 | 12 |
| Total, serious adverse events | Obese | 0 | 15 |
| Total, serious adverse events | Normal Weight | 0 | 12 |
Source ClinicalTrials.gov
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| U54HD058155 | Center for the Study of Reproductive Biology and Women's Health | POLLARD, JEFFREY W. | ALBERT EINSTEIN COLLEGE OF MEDICINE | EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT | 2009 to 2013 |
Source NIH RePORTER
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Obese vs Normal Weight: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01894581
GET https://conductscience.org/api/trials/v1/NCT01894581/registered